Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41